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Background
Little is known about the long-term outcome of anorexia
nervosa.
Aims
To study the 30-year outcome of adolescent-onset anorexia
nervosa.
Method
All 4291 individuals born in 1970 and attending eighth grade in
1985 in Gothenburg, Sweden were screened for anorexia ner-
vosa. A total of 24 individuals (age cohort for anorexia nervosa)
were pooled with 27 individuals with anorexia nervosa (identified
through community screening) whowere born in 1969 and 1971–
1974. The 51 individuals with anorexia nervosa and 51 school-
and gender-matched controls were followed prospectively and
examined at mean ages of 16, 21, 24, 32 and 44. Psychiatric
disorders, health-related quality of life and general outcome
were assessed.
Results
At the 30-year follow-up 96% of participants agreed to partici-
pate. There was no mortality. Of the participants, 19% had an
eating disorder diagnosis (6% anorexia nervosa, 2% binge-eating
disorder, 11% other specified feeding or eating disorder); 38%
had other psychiatric diagnoses; and 64% had full eating disorder
symptom recovery, i.e. free of all eating disorder criteria for
6 consecutive months. During the elapsed 30 years, participants
had an eating disorder for 10 years, on average, and 23% did not
receive psychiatric treatment. Good outcome was predicted by
later age at onset among individuals with adolescent-onset
anorexia nervosa and premorbid perfectionism.
Conclusions
This long-term follow-up study reflects the course of adolescent-
onset anorexia nervosa and has shown a favourable outcome
regarding mortality and full symptom recovery. However, one in
five had a chronic eating disorder.
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Follow-up studies of anorexia nervosa have been conducted since
the second half of the 20th century and were thoroughly reviewed
in 2009 by Steinhausen.1 According to the review, approximately
half of all individuals with anorexia nervosa were classified as
fully recovered, one in three had improved and one in five had a
chronic course of the disorder. The crude mortality rate was 5%.1
High mortality rates were also found in a meta-analysis reporting
a standardised mortality ratio of six for anorexia nervosa.2
According to Steinhausen, the outcome of adolescent-onset anor-
exia nervosa was more favourable in terms of mortality and chron-
icity than the outcome of anorexia nervosa with variable onset,
including patients with adult onset.1 All 119 patient series in the
Steinhausen review1 except two – the FinnTwin study3 and the
present study, i.e. the ‘Gothenburg anorexia nervosa study’,4–7 –
were based on clinical data.
Studies with exceptionally long observational periods
Three anorexia nervosa outcome studies (one from Germany,8 one
from the USA9 and one from Sweden10) report exceptionally long
observational periods of more than 20 years. All three studies
included patients only. Recovery from anorexia nervosa was
observed in 51% of patients after 21 years in the German study,8
in 63% of patients after 22 years in the American study9 and in
76% of patients after 33 years in the Swedish study.10 Two of the
studies reported crude mortality rate, corresponding to 16 and
18%, respectively.8,10 The three outcome studies either performed
personal interviews8,10 or telephone interviews9 at follow-up. Two
of the studies had a prospective design.8,9
Since 1985, we have carried out a prospective, longitudinal,
case–control study of individuals with adolescent-onset anorexia
nervosa. The individuals have been examined on four previous
occasions. The aims of the present study were as follows:
(a) to prospectively examine the very long-term outcomes of ado-
lescent-onset anorexia nervosa, including full recovery from
eating disorder symptoms, psychiatric morbidity, mortality,
global functioning and health-related quality of life (HRQoL).
(b) to identify predictors of outcome to determine risk factors for
developing anorexia nervosa.
For our study group we hypothesised that the outcomes of Global
Assessment of Functioning (GAF), HRQoL, eating disorder
outcome and psychiatric morbidity would be significantly worse
than for the matched comparison group. We hypothesised that
the outcomes within our study group would be better than the out-
comes of the clinical, long-term studies due to this sample being
partly community and population based and only including indivi-
duals with adolescent-onset anorexia nervosa.
Method
Study design and participants
The original study (study 1)
The anorexia nervosa group: In 1985, the so-called
Gothenburg anorexia nervosa study was initiated by M.R. and
C.G. All 4291 individuals born in 1970 and attending eighth
grade in Gothenburg underwent a physical examination and com-
pleted an eating disorder symptom questionnaire. All 4291* These authors contributed equally to this article.
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growth charts and questionnaires were scrutinised. All individuals
suspected to have anorexia nervosa were examined in person. All
children in special schools were assessed at the same time.
Regarding all boarding schools, M.R. established contact with the
school nurses and interviewed them regarding any child born in
1970 who could have anorexia nervosa. There were no cases of
home education. In the 1970 birth cohort, 23 girls and 2 boys met
criteria for anorexia nervosa before age 18. Only 1 girl declined
further examination, leaving 24 individuals (22 girls, 2 boys) in
the ‘population-based group’ (for further details see7). Three indivi-
duals from the population-based group fulfilled almost all the cri-
teria for anorexia nervosa according to the DSM-III-R (1987);
these participants were considered as partial cases. These three indi-
viduals met all criteria for anorexia nervosa shortly after study 1 (see
below). At the time of the epidemiological study, individuals with
anorexia nervosa, born in 1969 and 1971–1974, were also reported
to the researchers by the school health services after community
screening. In all, 27 adolescents (26 girls, 1 boy) formed the ‘popula-
tion-screening group’, which was not a clinical group. A third of the
population-screening group had not been in touch with any paediat-
ric, child and adolescent psychiatric or adult psychiatric service.
Due to the similar group structure, the two groups were pooled
together to form the ‘anorexia nervosa group’, consisting of 51 par-
ticipants with anorexia nervosa (48 girls, 3 boys).7 All 51 individuals
had been assigned a diagnosis of anorexia nervosa by a physician spe-
cialised in psychiatry (M.R.) and all met the DSM-III-R11 and the
DSM-IV (1994)12 criteria for anorexia nervosa. Therefore, all parti-
cipants were found to be true cases of the disorder. The mean age
at onset of anorexia nervosa was 14.3 years (range 10.0–17.2 years).
Comparison group: At the time of the anorexia nervosa
screening, a comparison group was recruited. For each of the 51 par-
ticipants with anorexia nervosa, the school health nurses selected a
same-gender classmate who was closest in age to the index child.
These comparison participants had no history of an eating disorder.
This group also consisted of 51 individuals (48 girls, 3 boys).
At the time of the original study (study 1), all 102 individuals
(51 anorexia nervosa, 51 comparison) underwent a physical and
psychiatric examination. The mothers were interviewed in a semi-
structured way and they completed questionnaires about the child’s
developmental history, psychiatric and personality traits, temperament,
interests and peer relationships. The assessment of childhood perfec-
tionism was made as a clinical judgement based on several-hours-
long interviews with the parents (e.g. including a semi-structured
validated interview).13 Information from a parental questionnaire,
the child healthcare centre and the patient registers were also used.
M.R. compiled case notes for all individuals. All information
that could raise suspicion that the child might have an eating
disorder had been excluded in these records. C.G., who was
blinded to group status, assigned psychiatric diagnoses (including
autism spectrum disorder [ASD]) and personality traits (including
perfectionism) based on the data from the case notes.7 In the
anorexia nervosa group, 12 participants had developed bulimia
nervosa after the onset of anorexia nervosa and a diagnosis of
bulimia nervosa was met either before or at study 1. This informa-
tion was based on growth charts, school nurse assessments and
questionnaires (and reported at study 1).7
Study 2, study 3 and study 4
The anorexia nervosa and comparison groups were followed up
6 years after the onset of anorexia nervosa (study 2; mean age
21 years), 10 years after onset (study 3; mean age 24 years) and
after 18 years (study 4; mean age 32 years). All 102 individuals
agreed to participate in all follow-up studies.
Study 5 (the present study)
All 102 participants were traced. Four individuals in the anorexia
nervosa group (two women, two men) declined participation (one
man lived abroad and worked ‘12–15 h a day’, one woman was
too disabled due to an anxiety disorder and one man and one
woman were not comfortable taking part in the research project),
leaving 47 participants (46 women, 1 man; 36 face-to-face inter-
views, 11 online video conferences/telephone interviews) in the
anorexia nervosa group. All 51 individuals (48 women, 3 men;
42 face-to-face interviews, 9 online video conferences/telephone
interviews) in the comparison group agreed to participate. In all, 98
out of 102 individuals participated in the study (drop-out rate 4%).
This study was approved by the Regional Ethical Review Board
at the University of Gothenburg (398–14) and followed the World
Medical Association’s Declaration of Helsinki. The individuals par-
ticipated voluntarily. Written informed consent was obtained from
all participants.
Procedures
The Mini-International Neuropsychiatric Interview (MINI 6.0)14
was used. Two of the individuals in the anorexia nervosa group
only agreed to participate in a short interview and therefore the
MINI was conducted to 45 out of the 47 participants in the anorexia
nervosa group. The eating disorder module of the MINI was consid-
ered too brief, and therefore the eating disorder domain of the
Structured Clinical Interview for DSM-IV (SCID-I)15 and a DSM-
5 (2013) checklist for feeding and eating disorders were added. In
the present study the DSM-5 criteria for feeding and eating disor-
ders have been applied.16
The GAF was used to assess general outcome. The Morgan–
Russell scales were used to calculate a ‘Morgan–Russell averaged
scale score’, which is a composite score summarising body and
weight concern, dieting, body weight, menstrual status, mental
state, attitudes toward sexual relationships and menstruations,
social relationships with family and friends, and employment
during the past 6 months. TheMorgan–Russell scales are well estab-
lished and the best-validated outcome instruments in anorexia
nervosa research.17
The 36-item Short Form Health Survey (SF-36),18 a generic
HRQoL instrument, is the most frequently applied HRQoL meas-
urement in eating disorders.19 It consists of four physical and four
mental subscales. The instrument includes two composite scores:
the Physical Composite Score (PCS) and the Mental Composite
Score (MCS).
Full recovery from eating disorder symptoms
In accordance with our definition of full recovery from eating dis-
order symptoms in study 3 and study 4,5,6 informed by Strober
et al,20 a fully recovered individual ‘refers to patients who have
been free of all criterion symptoms of anorexia nervosa or bulimia
nervosa for not less than 8 consecutive weeks’. It requires ‘the sus-
tained absence of weight deviation, compensatory behaviours, and
deviant attitudes regarding weight and shape, including weight
phobia’. In our sample, we also required being free from all criteria
of binge-eating disorder and that the individuals had been free
from the above symptoms for a minimum of 6 months. In the
present study information was obtained from the MINI, SCID-I,
the DSM-5 checklist for feeding and eating disorders and the
Morgan–Russell scales.
Statistical analyses
Mainly non-parametric tests were used, due to the scale scores not
being normally distributed. The chi-squared test or Fisher’s exact
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test were used for dichotomous variables and the Mann–Whitney
test for continuous variables. To assess change over time,
McNemar’s test and the Wilcoxon signed-rank test were used for
dichotomous and continuous variables, respectively. A P-value of
<0.05 was regarded as statistically significant. In cases of multiple
comparisons, the upper limit of false significance was calculated
as follows: (number of tests− number of significant tests on signifi-
cance level 0.05)*0.05/(1–0.05).
Predictive factors
Predictive factors were chosen in accordance with the 18-year
follow-up study (study 4)6 and focused mainly on variables mea-
sured at study 1 and on premorbid/retrospective childhood data.
The following predictors were investigated for their individual rela-
tionships with continuous outcome variables (GAF, Morgan–
Russell averaged scale score, PCS, MCS) and the dichotomous
outcome variable of full recovery from eating disorder symptoms:
age at onset of adolescent-onset anorexia nervosa and premorbid
body mass index (BMI); lowest BMI ever assessed at study 2 (con-
tinuous); perinatal factors and social class (ordinal); early gastro-
intestinal problems; primary amenorrhoea; premorbid problems
including problems with friends, major problems in the family,
major life events, parental divorce, death of family member; affect-
ive disorder; overweight; obsessive–compulsive disorder; obsessive–
compulsive personality traits; perfectionism; and ASD before study
1 and/or at study 2 (all dichotomous). Spearman correlations were
used to examine the association of two continuous/ordinal vari-
ables, Mann–Whitney test for the association of continuous/
ordinal with dichotomous variables and logistic regression for the
univariate associations of predictors with full recovery of eating dis-
order symptoms. Variables with P < 0.10 in the univariate tests were
included as possible predictors in the multiple stepwise regression
analyses (‘backward’ procedure in SPSS).
Results
There was no mortality. The mean ages at study 5 and the length of
the follow-up periods are presented in Supplementary Table S1
available at https://doi.org/10.1192/bjp.2019.113. Anthropometric
data are shown in Table 1.
General outcome
The outcome variables of the GAF and Morgan–Russell averaged
scale score were significantly lower in the anorexia nervosa group
(Table 1).
Changes in outcome between study 4 and study 5
Weight and BMI had increased significantly in the anorexia nervosa
and comparison group between study 4 and study 5 (Supplementary
Table S1). The GAF and Morgan–Russell averaged scale score had
not changed between the last two follow-ups in either group.
Eating disorders at study 5
Nine individuals (19%) in the anorexia nervosa group had a current
eating disorder, including three people with anorexia nervosa (two
classified as being in partial remission. If DSM-IV criteria had been
applied, one of the three people with anorexia nervosa would have
been classified as eating disorder not otherwise specified due to
regular menstruations) (Table 2). The mean duration of the first
episode of anorexia nervosa (calculated from onset of anorexia
nervosa) was 3.6 years (s.d. 3.0). The mean duration of all aggre-
gated episodes of anorexia nervosa was 4.9 years (s.d. 5.1). The
mean duration of all aggregated episodes of eating disorders
(including anorexia nervosa) was 10.2 years (s.d. 8.1).
Full recovery from eating disorder symptoms
In the anorexia nervosa group, 64% (n = 30) were considered fully
recovered. There was no significant difference in mean BMI
between recovered and non-recovered participants (recovered:
22.7 kg/m2, s.d. 3.1; non-recovered: 24.5 kg/m2, s.d. 7.2; P = 0.24).
The three individuals with current anorexia nervosa, including the
two in partial remission, had a mean BMI of 19.7 kg/m2 (s.d. 3.1,
range 16.3–22.4). Those with full recovery of eating disorder symp-
toms had significantly better outcome according to the GAF and
Morgan–Russell averaged scale score than those without full
eating disorder symptom recovery.
Changes in eating disorder diagnoses between study 4
and study 5 and over 30 years
Between the two most-recent follow-up studies, 17% (n = 8) of par-
ticipants fulfilled the criteria for anorexia nervosa at some point and
32% (n = 15) had experienced any type of eating disorder (including
anorexia nervosa) (Table 2; Supplementary Figure S1). Figure 1
shows the trajectories of the individuals’ eating disorders over
30 years. All of those who had anorexia nervosa at study 4 were
now free from any eating disorder. Figure 2 shows BMI over 30 years.
Other psychiatric disorders at study 5
Psychiatric morbidity was significantly over-represented in the
anorexia nervosa group (Table 2). DSM-5 anxiety disorders were
the most common psychiatric disorders in both groups, but they
were significantly more common in the anorexia nervosa group
(Table 2).
Changes in other psychiatric disorders between study 4
and study 5 and over 30 years
Between the two most-recent follow-up studies, psychiatric diagno-
ses were significantly more common in the anorexia nervosa group
than in the comparison group (Table 2). The percentages of psychi-
atric disorders in the original study and across the four follow-up
studies are available in Figure S2.
Treatment received
In the anorexia nervosa group, 23% had never received treatment
for an eating disorder. Only two individuals were in current treat-
ment for an eating disorder at study 5, including one person with
anorexia nervosa who received compulsory treatment. According
to the mean Morgan–Russell averaged scale score and the mean
GAF there was no difference between those who had ever received
treatment for an eating disorder and those who had not received
treatment.
HRQoL
A total of 37 people from the anorexia nervosa group and 47 from
the comparison group completed the SF-36 (Table S2). A drop-out
analysis showed that people in the anorexia nervosa group who
completed the survey had a significantly lower mean GAF score
(58.3) than those who did not (69.8; P = 0.043), and psychiatric
comorbidity was more common in those who completed the
survey than in those that did not (P = 0.015). The MCS was signifi-
cantly lower in the anorexia nervosa group (Supplementary
Table S2). Neither the mental subscale scores nor the MCS were sig-
nificantly lower among those in the anorexia nervosa group with a
current eating disorder. Individuals in the anorexia nervosa group
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with a current psychiatric morbidity scored significantly lower in all
subscale and composite scores than individuals without a psychi-
atric disorder.
Correlations between previously diagnosed ASD and
other variables
Our four previous studies have shown that 12% (n = 6) of the anor-
exia nervosa group had ASD at all four examinations (ASDx4).6 At
study 5, the mean GAF and Morgan–Russell averaged scale score
were significantly lower in the ASDx4 group compared with the
remainder of the anorexia nervosa group. No individuals in the
ASDx4 group had a current eating disorder at study 5.
Predictive factors for good outcome
Stepwise linear regression analysis revealed that higher age at onset
of adolescent-onset anorexia nervosa and perfectionism before onset
of anorexia nervosa were individual predictors for better outcome on
GAF, Morgan–Russell averaged scale score and MCS. Additionally,
early gastrointestinal problems were an individual predictor for
better outcome on the Morgan–Russell averaged scale score. In the
stepwise logistic regression for full recovery from eating disorder
symptoms, higher age at onset of adolescent-onset anorexia
nervosa was a significant predictor (Tables S3 and S4).
Discussion
This unique, controlled, 30-year follow-up study of adolescent-
onset anorexia nervosa has shown that the majority of people
with this disorder do well in the long-term perspective. There was
no mortality, almost two-thirds reported full recovery from eating
disorder symptoms and physical aspects of quality of life were
similar across the anorexia nervosa and comparison groups.
However, eating disorders were still present in a minority, affecting
one in five.
Due to the sample being partly population based and including
only cases of adolescent-onset anorexia nervosa, we had hypothe-
sised that the outcome of our anorexia nervosa group would be
better than other very long-term outcome studies. With no deaths
in our sample, we had better mortality results than clinical
outcome studies. Our findings were in line with the community-
based FinnTwin study, which reported no mortality after 10
years.21 The proportion of full recovery from eating disorder symp-
toms (64% in our anorexia nervosa group) was not better than that
seen in clinical studies with follow-up periods of more than 20
years.8–10
One other study has an observational period of more than 30
years.10 The sample had been admitted to hospital during the
period 1931–1960. Given that no evidence-based treatment for
anorexia nervosa had been developed during that period, it is sur-
prising that 76% of the sample had recovered after 33 years.
However, the mortality rate of 18% may be an indication of the
lack of knowledge about eating disorders in health services at the
time. Only 6% of participants had an eating disorder after 33
years.10 In our 18-year follow-up, we found 12% with an eating dis-
order.6 We expected to find, if anything, lower rates at the 30-year
follow-up, but instead we saw a small increase. We were surprised to
find that a third of the anorexia nervosa group fulfilled an eating dis-
order diagnosis during the past 12 years. However, this is in line
with a recent 20-year follow-up study of in-patients with anorexia
nervosa that showed a remission rate of only 39%. In that study,
Table 1 Comparisons between the anorexia nervosa and the comparison group regarding outcome variables and changes between baseline and study
5, and between study 4 and study 5
Baseline Anorexia nervosa study 4 Anorexia nervosa study 5
Anorexia
nervosa group
(N = 51)
Comparison
group
(N = 51)
P
Anorexia
nervosa
group
(N = 51)
Comparison
group
(N = 51)
P
Anorexia
nervosa
group
(N = 47)a
Comparison
group
(N = 51)
PMean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
Morgan–Russell
averaged scale
score
n/a n/a 9.74 2.08 11.02 1.17 <0.0001 9.60 1.82 10.67 1.63 0.003
GAF n/a n/a 65.18 17.98 82.39 12.84 <0.0001 60.72 17.23 80.20 14.78 <0.0001
Weight 49.52b 8.73 55.99 6.67 <0.0001 62.26 13.26 66.69 11.01 0.069 64.55 13.38 70.43 13.61 0.034
Height 164.61 6.95 167.08 7.42 0.06 166.78 6.52 169.00 7.03 0.101 166.20 5.97 169.09 6.80 0.028
BMI 18.28 2.90 20.02 1.75 <0.0001 22.36 4.55 23.41 4.21 0.23 23.36 5.00 24.72b 4.92 0.18
Change: baseline to study 5 Change: study 4 to study 5
Anorexia nervosa group
(N = 47)
Comparison group
(N = 51)
Anorexia nervosa group
(N = 47)a
Comparison group
(N = 51)
Mean s.d. P Mean s.d. P Mean s.d. P Mean s.d. P
Morgan–Russell averaged
scale scorec
n/a n/a −0.18 1.60 0.337 −0.35 1.12 0.062
GAFd n/a n/a −4.19 13.67 0.065 −2.20 11.04 0.133
Weighte 15.63 14.16 <0.0001 14.50b 10.71 <0.0001 3.36 7.11 0.003 3.96b 6.18 <0.0001
Heightf 1.71 3.47 <0.0001 2.01 3.89 <0.0001 −0.15 0.86 0.224 0.09 0.87 0.677
BMIg 5.31 5.16 <0.0001 4.69 3.87 <0.0001 1.23 2.57 0.002 1.34b 2.22 <0.0001
‘Baseline’ corresponds to study 1 (the original study), when the anorexia nervosa screening was performed. Average minimum BMI at the time was 14.9 kg/m2 (s.d. 2.6) in the anorexia
nervosa group. Out of 51 individuals in the anorexia nervosa group, 12 no longer fulfilled an anorexia nervosa diagnosis at the time of study 1. Due to multiple comparisons the upper limit of
false significance was calculated to be 1.2. Study 4, 18-year follow-up; study 5, 30-year follow-up/the present study; n/a, not applicable; GAF, Global Assessment of Functioning; BMI, body
mass index (kg/m2).
a. Two out of three males did not participate.
b. Based on 50 individuals.
c. Change from study 4 to study 5, anorexia nervosa versus comparison group: P = 0.547.
d. Change from study 4 to study 5, anorexia nervosa versus comparison group: P = 0.427.
e. Change from study 4 to study 5, anorexia nervosa versus comparison group: P = 0.654.
f. Change from study 4 to study 5, anorexia nervosa versus comparison group: P = 0.173
g. Change from study 4 to study 5, anorexia nervosa versus comparison group: P = 0.832.
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remission was defined as not fulfilling any eating disorder diagnosis
(including ‘eating disorder syndrome below the threshold of
DSM-IV’) for the past 3 months.22
The prospective design enabled us to study the individual trajec-
tories of anorexia nervosa and crossover from one eating disorder to
another. Between the 18- and 30-year follow-up, one in five had an
eating disorder relapse. Diagnostic crossover involving anorexia
nervosa, binge-eating disorder and other specified feeding or
eating disorder was also common during this follow-up period. At
the 10-year follow-up, study 3,5 half of the anorexia nervosa
group had met criteria for bulimia nervosa at some point, which
is in line with other long-term follow-up studies.20 However, from
study 4 and onwards bulimia nervosa was no longer observed
among the individuals in the anorexia nervosa group.
In this study, one in four people had never received treatment
for an eating disorder. Nonetheless, treatment did not affect the
outcome 30 years after the onset of anorexia nervosa. However,
since the individuals were not randomly allocated to receive or
not receive treatment, these outcome results must be interpreted
with caution. Our finding is in accordance with a 5-year follow-
up study of eating disorders where treatment did not affect the
outcome of any eating disorder.23 Our results may reflect that indi-
viduals with anorexia nervosa are reluctant to undergo treatment
and there is meagre scientific evidence for anorexia nervosa treat-
ment per se, with least evidence for adult patients.19 The resistance
to recovery posits anorexia nervosa among themost difficult psychi-
atric disorders to treat.
Regarding HRQoL, the PCS reflected a good outcome in the
anorexia nervosa group, but the MCS did not. The lower MCS
results could partly be explained by a significant over-representa-
tion of psychiatric morbidity and lower mean GAF among those
who completed the SF-36 compared with those who did not. In
our sample individuals with a current eating disorder did not
express worse HRQoL compared with those who had no current
eating disorder, whereas Eddy’s group9 found the physical and psy-
chological aspects of HRQoL to be significantly poorer among
people with unrecovered anorexia nervosa at the 22-year follow-
up. In a community-based study using the SF-36, individuals with
a self-reported history of anorexia nervosa had a poorer HRQoL
than those who did not have a history of anorexia nervosa.24
Later age at onset among individuals with adolescent-onset
anorexia nervosa predicted good outcome, i.e. adolescent onset is
better than childhood onset according to the GAF and the
Morgan–Russell averaged scale score. This is consistent with
outcome studies of childhood-onset anorexia nervosa,25 where the
illness ‘often takes a chronic and disabling course with highmorbid-
ity rates’.25 The individuals in our study with the lowest ages of onset
were in the same age range as the oldest children in the outcome
studies of childhood-onset anorexia nervosa (which had an inclu-
sion criterion of onset of anorexia nervosa before age 14).25
Premorbid perfectionism was a favourable prognostic factor even
though premorbid perfectionism has often been reported as a risk
factor for developing anorexia nervosa.26 Clinical perfectionism
may maintain the eating disorder psychopathology27 and therefore
an eating disorder treatment designed to produce enduring change,
enhanced cognitive–behavioural therapy, has included a module for
reducing clinical perfectionism. In contrast, perfectionism has been
shown to persist in individuals with good outcome and anorexia
nervosa recovery.28 Could it be that the perfectionism that drove
the illness was diverted to driving recovery, i.e. perfectionism can
both help and hinder in attaining a goal? Early severe gastrointes-
tinal problems also predicted a good outcome in the present
study. In our original study, M.R. found that half the individuals
in the anorexia nervosa group had an early history of severe gastro-
intestinal problems.7 These symptoms may reflect an immature
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gastrointestinal tract that caused a great deal of concern in child-
hood and during adolescence and therefore contributed to the
development of anorexia nervosa, but was subsequently not a risk
factor for perpetuating anorexia nervosa.
Strengths and limitations
To our knowledge, this is the only study that has followed people
with adolescent-onset anorexia nervosa and matched comparison
participants prospectively for 30 years. The sample is community
based and half of the participants with anorexia nervosa constitute
a total birth cohort. However, some factors may have influenced the
course of the illness. Even if all individuals were initially identified
in the community, half the group included a greater proportion of
individuals who had been in contact with treatment facilities. The
majority of individuals received treatment at some point, as
opposed to the FinnTwin study where only half of the participants
had been detected in the healthcare system.3 Even though some
individuals in our anorexia nervosa group did not seek treatment,
onemust bear inmind that identifying and following the individuals
prospectively for 30 years could be considered an intervention.
The comparison group was matched for age, gender and school,
and has been followed since the original study.Only two other research
groups have included a comparison group in their follow-up studies of
anorexia nervosa.29,30 The drop-out rate after 30 years was extremely
low; 96% agreed to examination for the fifth time in this project. The
prospective design made it possible to study each individual’s eating
disorder trajectory in detail over a period of 30 years.
27
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16
AN study 1
(16)
AN study 2
(21)
AN study 3
(24)
AN study 4
(32)
AN study 5
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2 )
Fig. 2 Bodymass index (BMI) in the anorexia nervosa and comparison group in the original study and across the four follow-up studies. Average
BMI in each group at each of the five assessments is displayed. The number below each study indicates the mean age of all participants at that
assessment. Error bars indicate 95% CI. AN, anorexia nervosa; AN study 1, the original study; AN study 2, 6-year follow-up; AN study 3, 10-year
follow-up; AN study 4, 18-year follow-up; AN study 5, 30-year follow-up (the present study); COMP, comparison.
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Fig. 1 The trajectories of eating disorders over 30 years. The eating disorder diagnoses at each of the five assessments for all 51 individuals in
the anorexia nervosa group is shown. The numbers before the abbreviations in the boxes correspond to the number of individuals with the
condition. The column to the left shows the number of the study and, within brackets, themean age of the anorexia nervosa group at the time of
the study. From study 1 to study 4 the eating disorder diagnoseswere assigned according to the DSM-IV; the DSM-5 criteriawere applied at study
5. AN, anorexia nervosa; BE, binge-eating disorder; BN, bulimia nervosa; DO, dropped out; ED, eating disorder not otherwise specified (other
specified feeding or eating disorder according to the DSM-5); NO, no eating disorder.
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One of the weaknesses of this study pertains to the sample size:
47 individuals with adolescent-onset anorexia nervosa is a relatively
small number compared with other very long-term studies where
84–1218–10 patients were followed up. However, the present
study is the only one that can claim representativeness, with its
population-/community-based design.
Individuals who decline participation in a follow-up study may
represent those with the worst outcome.9 Our drop-out rate was 4%,
corresponding to four individuals of the anorexia nervosa group.
We had at least some follow-up information on all non-participants;
we had been in touch with all of them and at least half of them
worked full time. Based on these data we do not believe that our
small group of non-participants represents those with the worst
outcome.
Our definition of recovery (full recovery from eating disorder
symptoms for a minimum of 6 consecutive months) could be ques-
tioned and it may have been better to use a longer time period. Some
researchers have argued for a 1-year period without eating disorder
behaviours, due to the risk of relapse being greatest within 1 year
post-treatment or post-recovery.20,31 Our definition of recovery
includes physical (BMI), behavioural (absence of binge eating, com-
pensatory behaviours and restrictive eating) and psychological
(body image concerns and fear of weight gain) aspects. Khalsa
et al31 have reported that an instrument measuring psychological
symptoms of eating disorders, e.g. the Eating Disorder
Examination Questionnaire (EDE-Q),32 should be included in the
assessment, and that individuals who exhibit full eating disorder
recovery should score in accordance with community norms.
A weakness of our study is that we did not use the EDE-Q as an
outcome measure and therefore the more detailed aspects of
eating disorder symptoms were not assessed. Each of the four
other anorexia nervosa studies with a follow-up period of 20 years
or more8–10,22 have used their own definition of recovery, with
one research group arguing that their more strict definition resulted
in a recovery rate of only 39%.22 According to a recent review of the
definition of recovery of anorexia nervosa, Khalsa et al31 conclude
that ‘to date there are no consensus guidelines available’ for research
purposes.
Another limitation is that referral to eating disorder specialist
treatment by the researchers during the 30-year follow-up period
may have affected the outcomes of the study. At study 2, only a
total of 37% of the population-based group had received treat-
ment.33 At study 3, study 4 and study 5 the individuals with
current anorexia nervosa did not agree to be referred to an eating
disorder service.
Clinical implications
Adolescent-onset anorexia nervosa carries a good ‘lifetime’ progno-
sis in terms of mortality and anorexia nervosa chronicity. However,
high prevalence of anorexia nervosa relapses between the 18-year
and the 30-year follow-ups indicates that late relapses occur, even
though some individuals had been free from an eating disorder
for one or two decades. As clinicians, we must be aware that a sub-
stantial minority of patients will continue to need psychiatric
expertise for their eating disorder or other psychiatric disorders
for many years.
Higher age at onset of adolescent-onset anorexia nervosa pre-
dicted better general outcome. This finding implies that – among
school health nurses, school doctors, child psychiatrists and paedia-
tricians – more effort needs to be made to detect individuals with a
very early onset of anorexia nervosa, i.e. in childhood and early ado-
lescence. With regard to the good outcomes predicted by premorbid
perfectionism in this study, premorbid and clinical perfectionism in
anorexia nervosa has traditionally been regarded as challenging by
clinicians in terms of treatment outcome and prognosis. Clinically
we may have to reconsider this dogma, at least in terms of the pre-
morbid traits. However, premorbid perfectionism has to our knowl-
edge not been reported as a good prognostic factor previously and
therefore our finding needs to be replicated before taking further
clinical actions.
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